REFERENCES
- Annemans, L.; Moeremans, K.; Lamotte, M.; Garcia Conde, J.; van denBerg, H.; Myint, H.; Pieters, R.; Uyttebroeck. A. Incidence, medical resource utilization and costs of hyperuricemia and tumor lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries. Leuk Lymphoma. 2003, 44, 77–83
- Inai, K.; Tsutani, H.; Ueda, T. Pathophysiology of hyperuricemia in hematologic disease (in Japanese). Gout Nucleic Acid Metab. 1999, 23, 182–186.
- Japanese Society of Gout and Nucleic Acid Metabolism. Guidelines for the Management of Hyperuricemia and Gout (Abridged edition). ed. Committee for the preparation of guidelines for the management of hyperuricemia and gout. Japan 2002.
- Cario, M.S.; Bishop, M. Tumour lysis syndrome; new therapeutic strategies and classification. Br. J. Haematol. 2004, 127, 3–11.
- Hand, K.R.; Garrow, G.C. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am. J. Med. 1993, 94, 133–139.